PlainPharmaWatch

CMS Open Payments · Program Year 2024

Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. reported $5,133,141.31 in payments to 13,236 physicians and teaching hospitals across 13,623 transactions.

See the rankings → How this is sourced
$5.1M
Total payments
13,623
Transactions
13,236
Recipients
−$1.4M
General Payments vs PY2023

Intercept Pharmaceuticals, Inc. reported $5,133,141.31 in payments to 13,236 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #269 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $387.82 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Intercept Pharmaceuticals, Inc. pairs top-quartile payment volume with a broadly spread payment pattern across many recipients.

#269
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Intercept Pharmaceuticals, Inc.'s CMS-reported General Payments decreased by $1.4M (−33.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: INTERCEPT PHARMACEUTICALS, INC.PY2023: INTERCEPT PHARMACEUTICALS, INC.PY2024: Intercept Pharmaceuticals, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$4.2MPY2024$2.8M
PY2023
$4,182,258.34
PY2024
$2,765,551.26

How Intercept Pharmaceuticals, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Intercept Pharmaceuticals, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$5,133,141 Top 14% higher than 86% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Intercept Pharmaceuticals, Inc.

Rank #269 of 1,925 companies in CMS Open Payments for 2024 belongs to Intercept Pharmaceuticals, Inc., which reported $5,133,141.31 across 13,623 transactions to 13,236 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $376.80 per transaction and $387.82 per recipient.

"Consulting Fee" leads the 7-category general-payment breakdown below at $1.5M (29.8% of the company's reported total, 113 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 7 types of general payments, Intercept Pharmaceuticals, Inc.'s largest category was "Consulting Fee" at $1.5M - 29.8% of the company's reported total.

How Intercept Pharmaceuticals, Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$1.5M2. Compensation for Faculty …$736.6K3. Food and Beverage$298.2K4. Honoraria$98.5K5. Travel and Lodging$76.4K6. Space Rental or Facility …$23.5K7. Education$415.34
Payment Type Amount Transactions
Consulting Fee $1.5M 113
Compensation for Faculty or Speaker (Medical Education) $736.6K 267
Food and Beverage $298.2K 12,596
Honoraria $98.5K 65
Travel and Lodging $76.4K 152
Space Rental or Facility Fees $23.5K 9
Education $415.34 34

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,379,968.00 (49.9%) of $2,765,551.26 in this company's General Payments records across 6,512 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Intercept Pharmaceuticals, Inc.

The five named recipients with the highest reported General Payments from this company

Haytham Elgammal$883.3KUniversity Of Iowa Hosp & Cl…$212.9KRobert Gish$134.4KRobert Brown$76.8KNezam Afdhal$72.6K
  1. 1

    Haytham Elgammal

    $883,348.88 across 16 reported transactions

  2. 2

    University Of Iowa Hosp & Clinics

    $212,853.17 across 27 reported transactions

  3. 3

    Robert Gish

    $134,404.04 across 53 reported transactions

  4. 4

    Robert Brown

    $76,795.91 across 10 reported transactions

  5. 5

    Nezam Afdhal

    $72,566.00 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $376.80. Average per recipient: $387.82.

Total Amount

$5,133,141.31

Avg per Transaction

$376.80

Avg per Recipient

$387.82

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Intercept Pharmaceuticals, Inc. Share

0.0%

#269 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Intercept Pharmaceuticals, Inc.

SK Life Science, Inc.

$5.1M 20,538 recipients

Pristine Surgical LLC

$5.1M 5 recipients

BrainScope Company, Inc.

$5.1M 25 recipients

Actelion Pharmaceuticals US, Inc.

$5.2M 31,311 recipients

ADC Therapeutics America, Inc.

$5.1M 4,269 recipients

Jcbd, LLC

$5.1M 10 recipients

Frequently Asked Questions

How much did Intercept Pharmaceuticals, Inc. pay to physicians and hospitals in 2024? ▾
Intercept Pharmaceuticals, Inc. made $5,133,141.31 in payments to physicians and hospitals in Program Year 2024, across 13,623 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Intercept Pharmaceuticals, Inc.? ▾
13,236 physicians and teaching hospitals received payments from Intercept Pharmaceuticals, Inc. in 2024, averaging $387.82 per recipient.
What types of payments did Intercept Pharmaceuticals, Inc. make? ▾
7 categories of general payment make up Intercept Pharmaceuticals, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $1.5M, representing 29.8% of the company's reported total.
How does Intercept Pharmaceuticals, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Intercept Pharmaceuticals, Inc. ranks #269 by total payment amount.
What is the average payment size from Intercept Pharmaceuticals, Inc.? ▾
In 2024, Intercept Pharmaceuticals, Inc. averaged $376.80 per transaction across 13,623 transactions to 13,236 recipients.
Where does the payment data for Intercept Pharmaceuticals, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Intercept Pharmaceuticals, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.